← All companies
OACC
Oaktree Acquisition Corp. III Life Sciences
$11.00
-0.00 -0.00%
Key statistics
from XBRL data in SEC filingsMarket cap
—
Revenue (TTM)
—
Net income (TTM)
$7.02M
EPS (TTM)
—
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
$1.28M
Total assets
$205M
Gross margin
—
52-week range
$10.46 – $12.47
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2026-03-31
May 13, 2026
10-K
Fiscal year ended 2025-12-31
Mar 26, 2026
10-Q
Quarter ended 2025-09-30
Nov 13, 2025
8-K
Director or officer change
Oct 29, 2025
8-K
Director or officer change
Oct 17, 2025
10-Q
Quarter ended 2025-06-30
Aug 12, 2025
8-K
Director or officer change
Jun 6, 2025
10-Q
Quarter ended 2025-03-31
May 14, 2025
10-K
Fiscal year ended 2024-12-31
Mar 27, 2025
8-K
Director or officer change
Jan 7, 2025
8-K
Other events
Dec 11, 2024
8-K
Unregistered sale of equity; Other events
Nov 5, 2024
8-K
Other events
Oct 31, 2024
8-K
Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Other events
Oct 25, 2024
Other filings
SCHEDULE 13G
May 15, 2026
SCHEDULE 13G
May 11, 2026
SCHEDULE 13G/A
Feb 11, 2026
3
Oct 29, 2025
3
Oct 22, 2025
SCHEDULE 13G/A
Aug 12, 2025
SCHEDULE 13G/A
Jul 15, 2025
3
Jun 16, 2025
SCHEDULE 13G/A
May 14, 2025
SCHEDULE 13G/A
May 14, 2025
SCHEDULE 13G
May 13, 2025
SCHEDULE 13G
May 9, 2025
SCHEDULE 13G
Feb 14, 2025
SCHEDULE 13G
Feb 12, 2025
SC 13G
AQR CAPITAL MANAGEMENT LLC
Nov 7, 2024
4
Oct 31, 2024
SC 13G
Oct 30, 2024
424B4
Oct 24, 2024
CERT
Oct 24, 2024
EFFECT
Item S-1; Item 2024-10-23; Item 16:30:00
Oct 23, 2024
3
Oct 23, 2024
3
Oct 23, 2024
3
Oct 23, 2024
3
Oct 23, 2024
3
Oct 23, 2024
3
Oct 23, 2024